Get started
Guided Therapeutics, Inc.Guided Therapeutics, Inc.Guided Therapeutics, Inc.

Guided Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

GTHP chart

Key stats

Market capitalization
‪5.06 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0737USD
Net income
‪−3.49 M‬USD
Revenue
‪98.00 K‬USD
Shares float
‪29.67 M‬
Beta (1Y)
−0.43

About Guided Therapeutics, Inc.

Sector
Health Technology
Industry
Medical Specialties
CEO
Mark L. Faupel
Website
guidedinc.com
Headquarters
Norcross
Employees (FY)
6
Founded
1992
ISIN
US40171F5017
FIGI
BBG000BQP3M1
Guided Therapeutics, Inc. is a medical technology company, which engages in developing medical devices. It also focuses on the selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The company was founded by Shabbir Bakir Bambot and Mark L. Faupel in 1992 and is headquartered in Norcross, GA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GTHP is 0.0995 USD — it has increased by 9.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Guided Therapeutics, Inc. stocks are traded under the ticker GTHP.
Guided Therapeutics, Inc. is going to release the next earnings report on May 20, 2024. Keep track of upcoming events with our Earnings Calendar.
GTHP stock is 8.54% volatile and has beta coefficient of −0.43. Check out the list of the most volatile stocks — is Guided Therapeutics, Inc. there?
Yes, you can track Guided Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
GTHP stock has fallen by 9.34% compared to the previous week, the month change is a 20.40% fall, over the last year Guided Therapeutics, Inc. has showed a 60.04% decrease.
GTHP net income for the last quarter is ‪−386.00 K‬ USD, while the quarter before that showed ‪−677.00 K‬ USD of net income which accounts for 42.98% change. Track more Guided Therapeutics, Inc. financial stats to get the full picture.
Today Guided Therapeutics, Inc. has the market capitalization of ‪5.53 M‬, it has decreased by 7.26% over the last week.
No, GTHP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GTHP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Guided Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GTHP reached its all-time high on Apr 6, 2016 with the price of 103550.3580 USD, and its all-time low was 0.0206 USD and was reached on Mar 29, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 6.00 employees. See our rating of the largest employees — is Guided Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Guided Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Guided Therapeutics, Inc. stock shows the strong sell signal. See more of Guided Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Guided Therapeutics, Inc. EBITDA is ‪−3.37 M‬ USD, and current EBITDA margin is ‪−3.44 K‬%. See more stats in Guided Therapeutics, Inc. financial statements.